MD4231C1 - Medicament based on troxerutin and carbazochrome for the treatment of portal gastropathies in hepatic cirrhosis - Google Patents

Medicament based on troxerutin and carbazochrome for the treatment of portal gastropathies in hepatic cirrhosis

Info

Publication number
MD4231C1
MD4231C1 MDA20120102A MD20120102A MD4231C1 MD 4231 C1 MD4231 C1 MD 4231C1 MD A20120102 A MDA20120102 A MD A20120102A MD 20120102 A MD20120102 A MD 20120102A MD 4231 C1 MD4231 C1 MD 4231C1
Authority
MD
Moldova
Prior art keywords
gastropathies
portal
treatment
carbazochrome
troxerutin
Prior art date
Application number
MDA20120102A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD4231B1 (en
Inventor
Георге АНГЕЛИЧ
Ульвия МАММАДОВА
Олег КРУДУ
Виорел МОРАРУ
Original Assignee
Георге АНГЕЛИЧ
Ульвия МАММАДОВА
Олег КРУДУ
Виорел МОРАРУ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Георге АНГЕЛИЧ, Ульвия МАММАДОВА, Олег КРУДУ, Виорел МОРАРУ filed Critical Георге АНГЕЛИЧ
Priority to MDA20120102A priority Critical patent/MD4231C1/en
Publication of MD4231B1 publication Critical patent/MD4231B1/en
Publication of MD4231C1 publication Critical patent/MD4231C1/en

Links

Abstract

The invention relates to medicine, particularly to hepatology and can be used for the treatment of portal gastropathies in hepatic cirrhosis.Summary of the invention consists in that a medicament is used on the basis of troxerutin and carbazochrome, in a dose of 300 mg and, respectively, 3 mg, for the treatment of portal gastropathies in hepatic cirrhosis. At the same time, the medicament is administered 1 tablet, 2…3 times daily, per os, during 14…30 days.
MDA20120102A 2012-11-08 2012-11-08 Medicament based on troxerutin and carbazochrome for the treatment of portal gastropathies in hepatic cirrhosis MD4231C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20120102A MD4231C1 (en) 2012-11-08 2012-11-08 Medicament based on troxerutin and carbazochrome for the treatment of portal gastropathies in hepatic cirrhosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20120102A MD4231C1 (en) 2012-11-08 2012-11-08 Medicament based on troxerutin and carbazochrome for the treatment of portal gastropathies in hepatic cirrhosis

Publications (2)

Publication Number Publication Date
MD4231B1 MD4231B1 (en) 2013-06-30
MD4231C1 true MD4231C1 (en) 2014-01-31

Family

ID=48749682

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20120102A MD4231C1 (en) 2012-11-08 2012-11-08 Medicament based on troxerutin and carbazochrome for the treatment of portal gastropathies in hepatic cirrhosis

Country Status (1)

Country Link
MD (1) MD4231C1 (en)

Citations (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003864A1 (en) * 1984-03-01 1985-09-12 Casley Smith John Royle Treatment of high protein oedemas by direct application of benzo-pyrones
CH671021A5 (en) * 1987-05-07 1989-07-31 Espanola Prod Quimicos Prodn. of hydroxy:ethylated diosmin mixts. - useful for treating intoxication
FR2661610A1 (en) * 1990-05-02 1991-11-08 Rhone Poulenc Sante Novel lyophilised form of diosmin and its preparation
FR2668705A1 (en) * 1990-11-06 1992-05-07 Bouchara Sa Novel skin preparations having a phlebotonic action and process for preparing them
EP0541874A1 (en) * 1990-05-11 1993-05-19 Jérôme CORBIERE Compositions containing diosmin
FR2692145A1 (en) * 1992-06-10 1993-12-17 Bellon Labor Sa Roger Topical compsns. having a vascular protecting and veinotonic action - contain diosmin, fatty acid(s), hydrating agent, neutralising agent, gelling agent and opt. stabilisers, preservatives, colours, perfumes, etc.
JPH08301757A (en) * 1995-05-10 1996-11-19 Kureha Chem Ind Co Ltd Hsp47 synthesis suppressing agent
NZ280418A (en) * 1994-11-08 1997-03-24 Adir Diosmin composition; effervescent granule, in tablet or sachet form containing micronised diosmin
CA2287363A1 (en) * 1997-05-13 1998-11-19 Remacle, Jose Use of a pharmaceutical composition for treating and/or preventing ischemia
DE19922287A1 (en) * 1998-05-15 1999-11-25 Coletica Lyon Cosmetic, dermatological, pharmaceutical, dietetic or food compositions, e.g. for improving skin condition, comprise flavonoid esters
JP2000023635A (en) * 1998-07-10 2000-01-25 M P G Kk Granule nutrient auxiliary food
WO2000015237A1 (en) * 1998-09-15 2000-03-23 Korea Research Institute Of Bioscience And Biotechnology Composition containing rutin and quercetin for preventing or treating elevated blood lipid level-related diseases
KR20000019719A (en) * 1998-09-15 2000-04-15 박호군 Composition comprising diosmin for preventing and treating hyperlipidemia and arteriosclerosis
KR20010007624A (en) * 2000-10-06 2001-01-26 박호군 Composition for preventing and treating atherosclerosis, hyperlipidemia, hepatic diseases and glycosemia, comprising neohesperidin dihydrochalcone
KR20010007625A (en) * 2000-10-06 2001-01-26 박호군 Composition for preventing and treating atherosclerosis and hyperlipidemia, comprising diosmin
WO2002020030A2 (en) * 2000-09-11 2002-03-14 Michael D Stander Use of buchu extracts for hypertension
WO2004032942A1 (en) * 2002-10-11 2004-04-22 Laboratoires Innothera Sas Dry oral phlebotonic and vasculoprotective formulation for the treatment of venous insufficiency, capillary fragility and haemorrhoids, in the pharmaceutical form of a chewable tablet containing diosmin
FR2857665A1 (en) * 2003-07-16 2005-01-21 Centre Nat Rech Scient New 3-halo flavone derivatives useful for treating disorders involving an excess of oxidizing species, e.g. cancer, ischemic diseases, dermatosis, neurodegenerative diseases, inflammatory diseases
US20060040911A1 (en) * 2003-01-06 2006-02-23 Liao Benedict S Method for preventing and/or treating the cardiovascular and hepatic diseases induced by hyperlipidemia which comprises administered an effective amount of bioflavonoids extract derived from fructus crataegus (lipid metabolism and fructus crataegus)
CN1823807A (en) * 2006-01-11 2006-08-30 刘展欣 Micronize diosmin and hesperidine composition suppository
EP1707192A2 (en) * 2005-03-30 2006-10-04 Therapicon Srl Pharmaceutical composition
MX2007011002A (en) * 2007-09-07 2009-03-09 World Trade Imp Export Wtie Ag Pharmaceutical composition combining various venotonic and vasoprotective agents for the treatment of chronic venous insufficiency.

Patent Citations (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003864A1 (en) * 1984-03-01 1985-09-12 Casley Smith John Royle Treatment of high protein oedemas by direct application of benzo-pyrones
CH671021A5 (en) * 1987-05-07 1989-07-31 Espanola Prod Quimicos Prodn. of hydroxy:ethylated diosmin mixts. - useful for treating intoxication
FR2661610A1 (en) * 1990-05-02 1991-11-08 Rhone Poulenc Sante Novel lyophilised form of diosmin and its preparation
EP0541874A1 (en) * 1990-05-11 1993-05-19 Jérôme CORBIERE Compositions containing diosmin
FR2668705A1 (en) * 1990-11-06 1992-05-07 Bouchara Sa Novel skin preparations having a phlebotonic action and process for preparing them
FR2692145A1 (en) * 1992-06-10 1993-12-17 Bellon Labor Sa Roger Topical compsns. having a vascular protecting and veinotonic action - contain diosmin, fatty acid(s), hydrating agent, neutralising agent, gelling agent and opt. stabilisers, preservatives, colours, perfumes, etc.
FR2692145B1 (en) * 1992-06-10 1995-05-05 Bellon Labor Sa Roger New composition for topical use containing diosmin.
NZ280418A (en) * 1994-11-08 1997-03-24 Adir Diosmin composition; effervescent granule, in tablet or sachet form containing micronised diosmin
JPH08301757A (en) * 1995-05-10 1996-11-19 Kureha Chem Ind Co Ltd Hsp47 synthesis suppressing agent
CA2287363A1 (en) * 1997-05-13 1998-11-19 Remacle, Jose Use of a pharmaceutical composition for treating and/or preventing ischemia
DE19922287A1 (en) * 1998-05-15 1999-11-25 Coletica Lyon Cosmetic, dermatological, pharmaceutical, dietetic or food compositions, e.g. for improving skin condition, comprise flavonoid esters
JP2000023635A (en) * 1998-07-10 2000-01-25 M P G Kk Granule nutrient auxiliary food
WO2000015237A1 (en) * 1998-09-15 2000-03-23 Korea Research Institute Of Bioscience And Biotechnology Composition containing rutin and quercetin for preventing or treating elevated blood lipid level-related diseases
KR20000019719A (en) * 1998-09-15 2000-04-15 박호군 Composition comprising diosmin for preventing and treating hyperlipidemia and arteriosclerosis
WO2002020030A2 (en) * 2000-09-11 2002-03-14 Michael D Stander Use of buchu extracts for hypertension
KR20010007624A (en) * 2000-10-06 2001-01-26 박호군 Composition for preventing and treating atherosclerosis, hyperlipidemia, hepatic diseases and glycosemia, comprising neohesperidin dihydrochalcone
KR20010007625A (en) * 2000-10-06 2001-01-26 박호군 Composition for preventing and treating atherosclerosis and hyperlipidemia, comprising diosmin
WO2004032942A1 (en) * 2002-10-11 2004-04-22 Laboratoires Innothera Sas Dry oral phlebotonic and vasculoprotective formulation for the treatment of venous insufficiency, capillary fragility and haemorrhoids, in the pharmaceutical form of a chewable tablet containing diosmin
US20060040911A1 (en) * 2003-01-06 2006-02-23 Liao Benedict S Method for preventing and/or treating the cardiovascular and hepatic diseases induced by hyperlipidemia which comprises administered an effective amount of bioflavonoids extract derived from fructus crataegus (lipid metabolism and fructus crataegus)
FR2857665A1 (en) * 2003-07-16 2005-01-21 Centre Nat Rech Scient New 3-halo flavone derivatives useful for treating disorders involving an excess of oxidizing species, e.g. cancer, ischemic diseases, dermatosis, neurodegenerative diseases, inflammatory diseases
EP1707192A2 (en) * 2005-03-30 2006-10-04 Therapicon Srl Pharmaceutical composition
CN1823807A (en) * 2006-01-11 2006-08-30 刘展欣 Micronize diosmin and hesperidine composition suppository
MX2007011002A (en) * 2007-09-07 2009-03-09 World Trade Imp Export Wtie Ag Pharmaceutical composition combining various venotonic and vasoprotective agents for the treatment of chronic venous insufficiency.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Шерлок Ш., Дули Д. Заболевания печени и желчнных путей. Москва, 1999, с. 859 *

Also Published As

Publication number Publication date
MD4231B1 (en) 2013-06-30

Similar Documents

Publication Publication Date Title
MY159353A (en) Pirfenidone treatment for patients with atypical liver function
NZ732507A (en) Improved compositions for treating muscular dystrophy
EA201591679A1 (en) METHOD OF NON-TOXIC TREATMENT OF ABSTINENT, CAUSED BY MEDICINE
TN2017000554A1 (en) Novel combination for use in the treatment of cancer
CL2014002935A1 (en) Method to treat a human patient with multiple sclerosis with laquinimod, at a daily dose of about 1.2mg; an oral unit dosage form of 1.2 mg of laquinimod and a carrier
UA105191C2 (en) Treatment with pirfenidone of patients with abnormal liver function
PH12016502352A1 (en) Pharmaceutical composition
MX2017003780A (en) Pharmaceutical composition for treating ulcerative colitis.
MX2019008817A (en) Extended-release formulation for reducing the frequency of urination and method of use thereof.
MX2016008027A (en) Use of laquinimod to delay huntington's disease progression.
IN2015DN02999A (en)
MX2018011293A (en) Prolonged release pharmaceutical composition comprising cysteamine or salt thereof.
MD4231C1 (en) Medicament based on troxerutin and carbazochrome for the treatment of portal gastropathies in hepatic cirrhosis
MD4232B1 (en) Medicament based on troxerutin and carbazochrome for the treatment of progressive hepatic cirrhosis associated with heart failure
MX2016006375A (en) A combination of dosage units for use in the treatment of pre-term labour condition.
MD4458B1 (en) Use of Polybiolin drug in patients with liver cirrhosis
MD3987C2 (en) Use of Diosmine for the treatment of advancing hepatic cirrhosis associated with cardiac insufficiency
MX2015016678A (en) Pharmaceutical formulations comprising agomelatine in the form of agomelatine co-crystal with an organic acid.
MD3986C2 (en) Use of Diosmine for the treatment of portal gastropathies in the hepatic cirrhosis
UA95834U (en) Method for treating acute ischemic stroke
UA82250U (en) Method for treating patients with non-alcoholic fatty liver disease
UA93070U (en) Method of treatment of mucocutaneous candidiasis treatment with the patients having chronic pancreatitis
NZ600486A (en) Pirfenidone treatment for patients with atypical liver function
UA82641U (en) Method for treating neurosyphilis with parenchymatous alterations
UA101141U (en) The method of correction of the dyslipidemia in patients with myocardial infarction in combination with nonalcoholic steatohepatitis

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)